Mixed Neoplasm — Trials

Mixed Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

451 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04906382	Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer	terminated	Early Phase 1	2	Floor Backes, MDOTHER	1	Feb 13, 2025	clinicaltrials

Data updated 22 days agoSource updated Feb 13, 2025source: clinicaltrials